Posted on 9/23/20
DraftKings Appoint Jocelyn Moore and Valerie Mosley To Board
DraftKings Inc. (Nasdaq: DKNG) today announced that the Company’s Board of Directors has appointed Jocelyn Moore and Valerie Mosley as new directors effective as of September . . .
Posted on 9/22/20
Matthew Kohel Appointed Co-Chair of Goodell DeVries's Commercial Litigation Practice
Goodell DeVries is pleased to announce that Matthew D. Kohel has been appointed Co-chair of the firm's Commercial Litigation Practice Group.Matt is a partner with the . . .
Posted on 9/22/20
Ziopharm Oncology Appoints Kevin Buchi to Board
Ziopharm Oncology, Inc. (Nasdaq:ZIOP), today announced the appointment of J. Kevin Buchi to the Company’s Board of Directors and as Chair of the Board’s Audit Committee.
Posted on 9/22/20
Wills Elliman, Newmark Interview with Patrick Callahan, Founder & CEO, CompassRed
Patrick believes that somewhere in the world's data is the cure for cancer, we just have to get the right people close to that data to . . .
Posted on 9/21/20
Nikola Executive Chairman Trevor Milton Steps Down
This morning, Nikola Corporation (NASDAQ: NKLA) Founder and Executive Chairman Trevor Milton announced that he is stepping down from his role with the Company.
Posted on 9/22/20
Henry Mortimer, citybiz Editor-at-Large, Interview with Mark Olcott, CEO of VitusVet
Helping Veterinarians Run Their Practices More Efficiently — and Making Pets Healthier By Henry Mortimer, citybiz Editor-at-Large Any breakdown in communication can jeopardize the important relationship between . . .
Posted on 9/18/20
The TJX Companies Appoints José B. Alvarez to Board
The TJX Companies, Inc. (NYSE:TJX), the leading off-price apparel and home fashions retailer in the U.S. and worldwide, today announced that on September 16, 2020,
Posted on 9/17/20
Praxis Precision Medicines Appoints Dean J. Mitchell as Chairman
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for people with central nervous system (CNS)
Posted on 9/20/20
Melina Sánchez Montañés, Impact First Investments, Interview with Irad Eichler, CEO at 7Chairs
Irad Eichler is a social entrepreneur who co-founded 7Chairs in 2019. 7Chairs is a teletherapy startup focused on providing emotional support to everyone who is dealing with . . .
Posted on 9/17/20
Cue Biopharma Appoints Tamar Howson To Board
Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted
Posted on 9/16/20
Revitope Oncology Appoints Carsten Reinhardt, M.D., Ph.D., to Board
Revitope Oncology, Inc., a biotechnology company advancing a new class of precision cancer immunotherapies today announced the appointment of life sciences industry veteran Carsten Reinhardt, M.D., . . .
Posted on 9/16/20
Advisor360 Appoints William D. Green to Board
Advisor360°, provider of a unified, integrated software suite for advisors, clients, and Broker-Dealers/Rollup-RIAs today announced that seasoned enterprise IT industry veteran William (Bill) D. Green has . . .
Posted on 9/16/20
Acceleron Appoints Laura J. Hamill to Board
Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics
Posted on 9/16/20
Voyager Therapeutics Appoints Nancy Vitale to Board
Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases
Posted on 9/15/20
Aviceda Therapeutics Appoints Chris Adams, PhD, MBA, and Nancy K. Thomason, MBA to Board
Aviceda Therapeutics is a pre-clinical stage biotech company focused on the next generation of glycol-immune therapeutics utilizing the Glyco-Code technology to address
Posted on 9/15/20
Ziopharm Oncology Appoints Adi Barzel, Gavin Dunn, Matthew Porteus and Kole Roybal to Scientific Advisory Board
BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced the appointment of four additional members to its Scientific Advisory Board (SAB). . . .
Posted on 9/15/20
Kronos Bio Appoints Elena Ridloff, CFA, to Board
Kronos Bio, Inc., a private clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient
Posted on 9/14/20
William D. Green Joins Advisor360° Board of Directors
Advisor360°, provider of a unified, integrated software suite for advisors, clients, and Broker-Dealers/Rollup-RIAs today announced that seasoned enterprise IT industry veteran William (Bill) D. Green has . . .
Posted on 9/14/20
Cerveau Technologies Announces Formation of Scientific Advisory Board
Cerveau Technologies, Inc. today announced formation of its Scientific Advisory Board (SAB), comprised of top tier physicians and scientists from around the globe, spanning areas of . . .
Posted on 9/14/20
Vizgen Appoints Terry Lo as CEO
Vizgen, the company illuminating biology with the next generation of spatially resolved, single-cell genomics tools, today announced the appointment of Terry Lo as President and Chief . . .
Posted on 9/13/20
Hubbell Names Gerben Bakker CEO
Hubbell Incorporated reported today that David G. Nord has announced his retirement as Chief Executive Officer of Hubbell Incorporated
Posted on 9/10/20
Cynosure Appoints Anne Gates to Board
Cynosure announced today that Anne Gates, former President at MGA Entertainment, the world's largest private toy company, and Executive Vice President and CFO of The Walt . . .
Posted on 9/10/20
CAIA Association Appoints Elizabeth Burton, CAIA and William Ma, CAIA to Board
The Chartered Alternative Investment Analyst (CAIA) Association, the professional body for the global alternative investment industry, today announced Elizabeth Burton, CAIA
Posted on 9/9/20
MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer
MetaboMed, a biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced the appointment of Ali Fattaey, Ph.D. as . . .
Posted on 9/9/20
Forma Therapeutics Appoints Thomas G. Wiggans to Board
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the appointment of industry veteran . . .
Boston
